Retrospective analysis shows potential for GLP-1s to treat blood clots

Max Gelman

Senior Editor

SAN DIEGO — As researchers explore more potential benefits of GLP-1 medicines, a new retrospective study is suggesting the drug class’ potential to treat venous …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Retrospective analysis shows potential for GLP-1s to treat blood clots

Max Gelman

Senior Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Sage sues Biogen days after $469M buyout offer

FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefit

A mixed year for deals and dollars left biotech execs hungry for a better 2025

What Trump's CMS can and can't change with the second round of drug price negotiations

Ozempic makes list for next round of Medicare drug price negotiations

Broad Institute paper offers potential new framework for treating Huntington’s disease

Ret­ro­spec­tive analy­sis shows po­ten­tial for GLP-1s to treat blood clots

Senior Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Retrospective analysis shows potential for GLP-1s to treat blood clots